Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.
Adult
Aged
Aged, 80 and over
Alphapapillomavirus
/ genetics
Biomarkers, Tumor
/ blood
Chemoradiotherapy
DNA, Viral
/ blood
Early Detection of Cancer
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
/ blood
Neoplasm, Residual
/ blood
Papillomavirus Infections
/ blood
Prospective Studies
Uterine Cervical Neoplasms
/ blood
Young Adult
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
received:
16
02
2021
revised:
22
04
2021
accepted:
28
06
2021
pubmed:
3
7
2021
medline:
1
4
2022
entrez:
2
7
2021
Statut:
ppublish
Résumé
Almost all cervical cancers are caused by human papillomavirus (HPV) and patients with advanced stage are at high risk for relapse. Circulating HPV DNA (HPV ctDNA) may serve as a residual tumor marker at the end of chemoradiation or to predict relapse during the follow-up period. We analyzed serum samples from 94 HPV16- or HPV18-related CCs from the BioRAIDs prospective cohort. Samples were collected before and after treatment and during an 18-month follow-up period. Using digital droplet PCR (ddPCR), we assessed the relevance of circulating HPV HPV HPV ctDNA detection is a useful marker to predict relapse in cervical cancer.
Identifiants
pubmed: 34210686
pii: 1078-0432.CCR-21-0625
doi: 10.1158/1078-0432.CCR-21-0625
pmc: PMC9401545
doi:
Substances chimiques
Biomarkers, Tumor
0
DNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5869-5877Commentaires et corrections
Type : CommentIn
Informations de copyright
©2021 The Authors; Published by the American Association for Cancer Research.
Références
Clin Cancer Res. 2019 Aug 1;25(15):4682-4690
pubmed: 31088830
EBioMedicine. 2020 Nov;61:103049
pubmed: 33096476
Sci Transl Med. 2015 Aug 26;7(302):302ra133
pubmed: 26311728
JCO Precis Oncol. 2018 Nov;2:1-8
pubmed: 35135145
Ann Oncol. 2018 Sep 1;29(9):1980-1986
pubmed: 30010779
Genome Med. 2018 Mar 20;10(1):21
pubmed: 29558971
J Transl Med. 2020 Apr 15;18(1):167
pubmed: 32293457
Biomolecules. 2020 Mar 07;10(3):
pubmed: 32156073
Clin Cancer Res. 2018 Nov 15;24(22):5767-5771
pubmed: 30054279
Br J Cancer. 2016 Dec 6;115(12):1575-1583
pubmed: 27875525
Gynecol Oncol. 2003 Jun;89(3):343-53
pubmed: 12798694
Gynecol Oncol. 2005 Oct;99(1):153-9
pubmed: 16054678
Int J Cancer. 2016 Nov 1;139(9):2001-11
pubmed: 27343048
PLoS One. 2012;7(8):e43393
pubmed: 22937045
ESMO Open. 2021 Jun;6(3):100106
pubmed: 33865192
J Natl Cancer Inst. 2005 Dec 21;97(24):1816-21
pubmed: 16368943
J Natl Cancer Inst. 2005 Aug 17;97(16):1180-4
pubmed: 16106022
J Gynecol Oncol. 2016 Jul;27(4):e43
pubmed: 27171673
Sci Transl Med. 2016 Jul 6;8(346):346ra92
pubmed: 27384348
J Clin Oncol. 2014 Feb 20;32(6):579-86
pubmed: 24449238
Clin Cancer Res. 2019 Apr 1;25(7):2109-2115
pubmed: 30504426
Gynecol Oncol. 2017 Jan;144(1):34-39
pubmed: 27789082
Eur J Surg Oncol. 2017 May;43(5):949-962
pubmed: 28185687
Br J Cancer. 2017 Sep 5;117(6):876-883
pubmed: 28809864
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
J Clin Virol. 2019 May;114:32-36
pubmed: 30913520
EBioMedicine. 2019 May;43:253-260
pubmed: 30952619
BMC Cancer. 2015 Nov 04;15:842
pubmed: 26531748
Int J Cancer. 2017 Oct 15;141(8):1667-1670
pubmed: 28670746
Ann Oncol. 2017 Jul 1;28(suppl_4):iv72-iv83
pubmed: 28881916
Clin Cancer Res. 2017 Nov 15;23(22):6856-6862
pubmed: 28899967
Br J Cancer. 2021 Feb;124(4):777-785
pubmed: 33191407
Front Oncol. 2020 Apr 17;10:505
pubmed: 32363162
Int J Mol Sci. 2017 Sep 22;18(10):
pubmed: 28937589
J Pathol Clin Res. 2016 Jun 28;2(4):201-209
pubmed: 27917295
Int J Cancer. 2021 Feb 15;148(4):995-1005
pubmed: 32895945
J Clin Oncol. 2020 Apr 1;38(10):1050-1058
pubmed: 32017652
Nat Med. 2008 Sep;14(9):985-90
pubmed: 18670422
NPJ Genom Med. 2016 Mar 16;1:16004
pubmed: 29263809
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955
Int J Cancer. 2020 Aug 15;147(4):1222-1227
pubmed: 31756275